Drugs / Entecavir Tablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04157257 | Jul 2019 → Dec 2020 | chronic hepatitis B virus infection | Qilu Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Entecavir Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04157257 ↗ |